Ted Buchan & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Buy |
47,205
+14,235
| +43% | +$345K | 0.45% | 51 |
|
|
2025
Q1 | $835K | Buy |
32,970
+6,575
| +25% | +$167K | 0.4% | 51 |
|
|
2024
Q4 | $700K | Buy |
+26,395
| New | +$700K | 0.33% | 52 |
|
|
2023
Q4 | – | Sell |
-8,868
| Closed | -$294K | – | 83 |
|
|
2023
Q3 | $294K | Sell |
8,868
-2,270
| -20% | -$75.3K | 0.24% | 60 |
|
|
2023
Q2 | $409K | Sell |
11,138
-5,509
| -33% | -$202K | 0.31% | 53 |
|
|
2023
Q1 | $679K | Buy |
16,647
+2,049
| +14% | +$83.6K | 0.57% | 39 |
|
|
2022
Q4 | $748K | Buy |
+14,598
| New | +$748K | 0.69% | 34 |
|